» Articles » PMID: 7851758

The Yeast Translational Allosuppressor, SAL6: a New Member of the PP1-like Phosphatase Family with a Long Serine-rich N-terminal Extension

Overview
Journal Genetics
Specialty Genetics
Date 1994 Nov 1
PMID 7851758
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The allosuppressor mutation, sal6-1, enhances the efficiency of all tested translational suppressors, including codon-specific tRNA suppressors as well as codon-nonspecific omnipotent suppressors. The SAL6 gene has now been cloned by complementation of the increased suppression efficiency and cold sensitivity caused by sal6-1 in the presence of the omnipotent suppressor sup45. Physical analysis maps SAL6 to chromosome XVI between TPK2 and spt14. The SAL6 gene encodes a very basic 549-amino acid protein whose C-terminal catalytic region of 265 residues is 63% identical to serine/threonine PP1 phosphatases, and 66% identical to yeast PPZ1 and PPZ2 phosphatases. The unusual 235 residue N-terminal extension found in SAL6, like those in the PPZ proteins, is serine-rich. The sal6-1 mutation is a frameshift at amino acid position 271 which destroys the presumed phosphatase catalytic domain of the protein. Disruptions of the entire SAL6 gene are viable, cause a slight growth defect on glycerol medium, and produce allosuppressor phenotypes in suppressor strain backgrounds. The role of the serine-rich N terminus is unclear, since sal6 phenotypes are fully complemented by a SAL6 allele that contains an in-frame deletion of most of this region. High copy number plasmids containing wild-type SAL6 cause antisuppressor phenotypes in suppressor strains. These results suggest that the accuracy of protein synthesis is affected by the levels of phosphorylation of the target(s) of SAL6.

Citing Articles

Autophagy protects against de novo formation of the [PSI+] prion in yeast.

Speldewinde S, Doronina V, Grant C Mol Biol Cell. 2015; 26(25):4541-51.

PMID: 26490118 PMC: 4678013. DOI: 10.1091/mbc.E15-08-0548.


Modulation of efficiency of translation termination in Saccharomyces cerevisiae.

Nizhnikov A, Antonets K, Inge-Vechtomov S, Derkatch I Prion. 2014; 8(3):247-60.

PMID: 25486049 PMC: 4601251. DOI: 10.4161/pri.29851.


Eukaryotic release factor 1 phosphorylation by CK2 protein kinase is dynamic but has little effect on the efficiency of translation termination in Saccharomyces cerevisiae.

Kallmeyer A, Keeling K, Bedwell D Eukaryot Cell. 2006; 5(8):1378-87.

PMID: 16896221 PMC: 1539132. DOI: 10.1128/EC.00073-06.


Evidence that phosphorylation of human Upfl protein varies with intracellular location and is mediated by a wortmannin-sensitive and rapamycin-sensitive PI 3-kinase-related kinase signaling pathway.

Pal M, Ishigaki Y, Nagy E, Maquat L RNA. 2001; 7(1):5-15.

PMID: 11214180 PMC: 1370068. DOI: 10.1017/s1355838201000127.


Mtt1 is a Upf1-like helicase that interacts with the translation termination factors and whose overexpression can modulate termination efficiency.

Czaplinski K, Majlesi N, Banerjee T, Peltz S RNA. 2000; 6(5):730-43.

PMID: 10836794 PMC: 1369953. DOI: 10.1017/s1355838200992392.


References
1.
Szostak J, Rothstein R . Genetic applications of yeast transformation with linear and gapped plasmids. Methods Enzymol. 1983; 101:228-45. DOI: 10.1016/0076-6879(83)01017-4. View

2.
Stinchcomb D, Mann C, Davis R . Centromeric DNA from Saccharomyces cerevisiae. J Mol Biol. 1982; 158(2):157-90. DOI: 10.1016/0022-2836(82)90427-2. View

3.
Boeke J, Lacroute F, Fink G . A positive selection for mutants lacking orotidine-5'-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol Gen Genet. 1984; 197(2):345-6. DOI: 10.1007/BF00330984. View

4.
Himmelfarb H, Maicas E, Friesen J . Isolation of the SUP45 omnipotent suppressor gene of Saccharomyces cerevisiae and characterization of its gene product. Mol Cell Biol. 1985; 5(4):816-22. PMC: 366786. DOI: 10.1128/mcb.5.4.816-822.1985. View

5.
Reed K, Mann D . Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids Res. 1985; 13(20):7207-21. PMC: 322039. DOI: 10.1093/nar/13.20.7207. View